Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Mater Sci Mater Med ; 28(11): 178, 2017 Oct 04.
Article in English | MEDLINE | ID: mdl-28980112

ABSTRACT

Antibacterial monomers can combat oral biofilm acids and caries; however, little is known on whether quaternary ammonium monomers (QAMs) would induce drug persistence in oral bacteria. The objectives of this study were to investigate the interactions of Streptococcus mutans (S. mutans) with dimethylaminohexadecyl methacrylate (DMAHDM), and determine for the first time whether DMAHDM could induce persisters in S. mutans. DMAHDM was synthesized using a modified Menschutkin reaction. Dose-dependent killing curves and time-dependent killing curves of planktonic S. mutans and biofilms were determined to evaluate drug persistence, using chlorhexidine (CHX) as control. The inheritability assay, minimum inhibitory concentration (MIC) and live/dead biofilm assay were determined to investigate persister characteristics. DMAHDM matched the killing potency of the gold standard CHX against S. mutans biofilms. DMAHDM and CHX induced drug persistence in S. mutans biofilms but not in planktonic bacteria. S. mutans biofilm persistence was not inheritable in that the tolerance to DMAHDM or CHX of the surviving persisters in the initial population was not transferred to subsequent generations, as displayed by the inheritability assay. The MIC of S. mutans parental strain and induced persisters remained the same. The induced persisters in S. mutans biofilms could be eliminated via higher doses of 300 µg/mL of DMAHDM and CHX. In conclusion, this study showed for the first time that (1) DMAHDM induced persisters only in biofilms, but not in planktonic bacteria; and (2) both DMAHDM-induced and CHX-induced S. mutans persister biofilms could be completely eradicated by even higher concentrations of DMAHDM and CHX. More studies are needed on the induction of persisters in oral biofilms for the development and use of a new generation of antibacterial dental monomers and resins.


Subject(s)
Aminocaproates/pharmacology , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Dental Materials/pharmacology , Drug Resistance, Bacterial/drug effects , Methacrylates/pharmacology , Streptococcus mutans/drug effects , Aminocaproates/chemistry , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/chemistry , Dental Caries/microbiology , Dental Materials/adverse effects , Dental Materials/chemistry , Humans , Methacrylates/chemistry , Microbial Sensitivity Tests , Quaternary Ammonium Compounds/chemistry , Quaternary Ammonium Compounds/pharmacology , Resin Cements/adverse effects , Resin Cements/chemistry , Resin Cements/pharmacology , Streptococcus mutans/physiology
SELECTION OF CITATIONS
SEARCH DETAIL